Jupiter Neurosciences director files initial Form 3

JUPITER NEUROSCIENCES, INC. director Tomas Jan Philipson filed an initial Form 3 reporting his status as a director and not a ten percent owner.

Accepted by SEC EDGAR 07/01/2026 - 04:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. director Tomas Jan Philipson filed an initial Form 3 reporting his status as a director and not a ten percent owner. The filing shows no insider transactions, exercises, gifts, or tax withholdings and provides no derivative holdings information at this time.

Key Terms

reportingPersons, is_director, is_ten_percent_owner

3 terms

reportingPersons regulatory

""reportingPersons": [ { "name": "Philipson Tomas Jan""

is_director regulatory

""is_director": 1"

is_ten_percent_owner regulatory

""is_ten_percent_owner": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the JUNS Form 3 filing by Tomas Jan Philipson show?

The Form 3 shows Tomas Jan Philipson as a director of Jupiter Neurosciences and not a ten percent owner. It reports no insider transactions, no derivative exercises, and no gifts or tax withholdings in this initial ownership statement.

Did Tomas Jan Philipson buy or sell JUNS shares in this Form 3?

No, this Form 3 reports no buy or sell transactions by Tomas Jan Philipson. All transaction-related counts, including purchases, sales, exercises, gifts, and tax withholdings, appear as zero in the transaction summary for this filing.

What is the role of Tomas Jan Philipson at Jupiter Neurosciences (JUNS)?

The filing identifies Tomas Jan Philipson as a director of Jupiter Neurosciences, Inc. It confirms he is not reported as a ten percent owner and does not hold an officer position or other specified role based on this disclosure.

Does the JUNS Form 3 include any derivative securities for Tomas Jan Philipson?

No, the derivative section is empty, indicating no listed options, warrants, or other derivative positions. The derivative transaction count is zero, and the derivativeSummary array contains no entries for this reporting person.

Why is the JUNS Form 3 important for investors to understand?

Form 3 establishes an insider’s initial ownership status when they become a reporting person. For JUNS, it confirms Tomas Jan Philipson’s director role, non–ten percent owner status, and that there are currently no reportable insider transactions or derivative holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Philipson Tomas Jan

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HWY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/26/2026

3. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Tomas J. Philipson	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)